D
Description
Italian CDMO leader formed in 2024 from the merger of Mipharm and Doppel. Around 900 employees across four production plants (Milan, Piacenza, Ferrara), producing 200 million units annually with EUR 180M turnover. Comprehensive pharmaceutical forms from liquids to solids including oncology applications.